5.94
-0.05 (-0.83%)
| Penutupan Terdahulu | 5.99 |
| Buka | 6.01 |
| Jumlah Dagangan | 542,213 |
| Purata Dagangan (3B) | 345,722 |
| Modal Pasaran | 157,623,504 |
| Harga / Jualan (P/S) | 2.19 |
| Harga / Buku (P/B) | 4.49 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 4 Aug 2026 |
| Margin Keuntungan | -97.49% |
| Margin Operasi (TTM) | -108.82% |
| EPS Cair (TTM) | -2.14 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 14.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 72.70% |
| Nisbah Semasa (MRQ) | 14.82 |
| Aliran Tunai Operasi (OCF TTM) | -41.02 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -25.25 M |
| Pulangan Atas Aset (ROA TTM) | -26.88% |
| Pulangan Atas Ekuiti (ROE TTM) | -76.01% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Menurun |
| Medical Devices (Global) | Bercampur | Menurun | |
| Stok | CVRx, Inc. | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | -2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -2.5 |
| Purata | -1.00 |
|
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 4.26% |
| % Dimiliki oleh Institusi | 73.63% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |